Skip to main content
. 2025 Mar 15;15(3):1158–1173. doi: 10.62347/UMKG8609

Table 1.

Comparison of count data between patients in the validation and training sets

Variable Total Training set (n=428) Validation set (n=184) Statistic P
Age
    <45 279 189 90 1.173 0.279
    ≥45 333 239 94
BMI
    <24 kg/m2 208 151 57 1.062 0.303
    ≥24 kg/m2 404 277 127
Disease type
    Squamous cell carcinoma 544 380 164 0.298 0.862
    Adenocarcinoma 60 43 17
    Others 8 5 3
Tumor size
    <2 cm 302 203 99 2.199 0.333
    2-4 cm 273 199 74
    >4 cm 37 26 11
FIGO grading
    IB1 273 181 92 3.480 0.323
    IB2 217 157 60
    IB3 37 26 11
    IIA1 85 64 21
Differentiation degree
    Well differentiated 238 160 78 1.484 0.476
    Moderately differentiated 231 164 67
    Poorly differentiated 143 104 39
Lymphovascular invasion
    Without 130 89 41 0.170 0.680
    With 482 339 143
History of hypertension
    Without 102 72 30 0.025 0.875
    With 510 356 154
History of diabetes
    Without 71 51 20 0.137 0.711
    With 541 377 164
LNM
    Without 110 80 30 0.497 0.481
    With 502 348 154

Note: BMI, body mass index; FIGO, International Federation of Gynecology and Obstetrics; LNM, lymph node metastasis.